nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—chronic obstructive pulmonary disease	0.32	1	CbGaD
Fosphenytoin—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0539	0.117	CbGbCtD
Fosphenytoin—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0539	0.117	CbGbCtD
Fosphenytoin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0487	0.106	CbGbCtD
Fosphenytoin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0448	0.0975	CbGbCtD
Fosphenytoin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0448	0.0975	CbGbCtD
Fosphenytoin—ALB—Prednisone—chronic obstructive pulmonary disease	0.0349	0.076	CbGbCtD
Fosphenytoin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0344	0.0748	CbGbCtD
Fosphenytoin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.034	0.0739	CbGbCtD
Fosphenytoin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0232	0.0505	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0226	0.0492	CbGbCtD
Fosphenytoin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0222	0.0482	CbGbCtD
Fosphenytoin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0197	0.043	CbGbCtD
Fosphenytoin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0116	0.0252	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0109	0.0238	CbGbCtD
Fosphenytoin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000277	0.00157	CcSEcCtD
Fosphenytoin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.00155	CcSEcCtD
Fosphenytoin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00155	CcSEcCtD
Fosphenytoin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00154	CcSEcCtD
Fosphenytoin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00154	CcSEcCtD
Fosphenytoin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00153	CcSEcCtD
Fosphenytoin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00153	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00153	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00153	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00153	CcSEcCtD
Fosphenytoin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00153	CcSEcCtD
Fosphenytoin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00152	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00152	CcSEcCtD
Fosphenytoin—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00151	CcSEcCtD
Fosphenytoin—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00151	CcSEcCtD
Fosphenytoin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00151	CcSEcCtD
Fosphenytoin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00151	CcSEcCtD
Fosphenytoin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00151	CcSEcCtD
Fosphenytoin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.0015	CcSEcCtD
Fosphenytoin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00149	CcSEcCtD
Fosphenytoin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00149	CcSEcCtD
Fosphenytoin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00148	CcSEcCtD
Fosphenytoin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00148	CcSEcCtD
Fosphenytoin—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00148	CcSEcCtD
Fosphenytoin—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00148	CcSEcCtD
Fosphenytoin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00147	CcSEcCtD
Fosphenytoin—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00146	CcSEcCtD
Fosphenytoin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00146	CcSEcCtD
Fosphenytoin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00145	CcSEcCtD
Fosphenytoin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00145	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00144	CcSEcCtD
Fosphenytoin—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00144	CcSEcCtD
Fosphenytoin—Cough—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00144	CcSEcCtD
Fosphenytoin—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00143	CcSEcCtD
Fosphenytoin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00142	CcSEcCtD
Fosphenytoin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00142	CcSEcCtD
Fosphenytoin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00142	CcSEcCtD
Fosphenytoin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00142	CcSEcCtD
Fosphenytoin—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00141	CcSEcCtD
Fosphenytoin—Cough—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00141	CcSEcCtD
Fosphenytoin—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00141	CcSEcCtD
Fosphenytoin—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.0014	CcSEcCtD
Fosphenytoin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000246	0.0014	CcSEcCtD
Fosphenytoin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.0014	CcSEcCtD
Fosphenytoin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.0014	CcSEcCtD
Fosphenytoin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00139	CcSEcCtD
Fosphenytoin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00138	CcSEcCtD
Fosphenytoin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00138	CcSEcCtD
Fosphenytoin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00137	CcSEcCtD
Fosphenytoin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00137	CcSEcCtD
Fosphenytoin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00137	CcSEcCtD
Fosphenytoin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00137	CcSEcCtD
Fosphenytoin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00137	CcSEcCtD
Fosphenytoin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00137	CcSEcCtD
Fosphenytoin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00136	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00134	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00134	CcSEcCtD
Fosphenytoin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00134	CcSEcCtD
Fosphenytoin—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00134	CcSEcCtD
Fosphenytoin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00133	CcSEcCtD
Fosphenytoin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00133	CcSEcCtD
Fosphenytoin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00132	CcSEcCtD
Fosphenytoin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00132	CcSEcCtD
Fosphenytoin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.00132	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00132	CcSEcCtD
Fosphenytoin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00131	CcSEcCtD
Fosphenytoin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00131	CcSEcCtD
Fosphenytoin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00131	CcSEcCtD
Fosphenytoin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00131	CcSEcCtD
Fosphenytoin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00131	CcSEcCtD
Fosphenytoin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00129	CcSEcCtD
Fosphenytoin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00129	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00129	CcSEcCtD
Fosphenytoin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00129	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00127	CcSEcCtD
Fosphenytoin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00126	CcSEcCtD
Fosphenytoin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00126	CcSEcCtD
Fosphenytoin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00126	CcSEcCtD
Fosphenytoin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00125	CcSEcCtD
Fosphenytoin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00125	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00124	CcSEcCtD
Fosphenytoin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00124	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00123	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00122	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00122	CcSEcCtD
Fosphenytoin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00121	CcSEcCtD
Fosphenytoin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00121	CcSEcCtD
Fosphenytoin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00121	CcSEcCtD
Fosphenytoin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.00121	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000211	0.0012	CcSEcCtD
Fosphenytoin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.0012	CcSEcCtD
Fosphenytoin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000211	0.0012	CcSEcCtD
Fosphenytoin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00119	CcSEcCtD
Fosphenytoin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00119	CcSEcCtD
Fosphenytoin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00119	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00119	CcSEcCtD
Fosphenytoin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00119	CcSEcCtD
Fosphenytoin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00118	CcSEcCtD
Fosphenytoin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00118	CcSEcCtD
Fosphenytoin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00118	CcSEcCtD
Fosphenytoin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00118	CcSEcCtD
Fosphenytoin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00117	CcSEcCtD
Fosphenytoin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00117	CcSEcCtD
Fosphenytoin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.00117	CcSEcCtD
Fosphenytoin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00116	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00116	CcSEcCtD
Fosphenytoin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00115	CcSEcCtD
Fosphenytoin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00115	CcSEcCtD
Fosphenytoin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00115	CcSEcCtD
Fosphenytoin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00114	CcSEcCtD
Fosphenytoin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00114	CcSEcCtD
Fosphenytoin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00113	CcSEcCtD
Fosphenytoin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00113	CcSEcCtD
Fosphenytoin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00112	CcSEcCtD
Fosphenytoin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00112	CcSEcCtD
Fosphenytoin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00111	CcSEcCtD
Fosphenytoin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00111	CcSEcCtD
Fosphenytoin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00111	CcSEcCtD
Fosphenytoin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00111	CcSEcCtD
Fosphenytoin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00111	CcSEcCtD
Fosphenytoin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00111	CcSEcCtD
Fosphenytoin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.0011	CcSEcCtD
Fosphenytoin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.0011	CcSEcCtD
Fosphenytoin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00108	CcSEcCtD
Fosphenytoin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00108	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00108	CcSEcCtD
Fosphenytoin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00107	CcSEcCtD
Fosphenytoin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00107	CcSEcCtD
Fosphenytoin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00106	CcSEcCtD
Fosphenytoin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00106	CcSEcCtD
Fosphenytoin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00106	CcSEcCtD
Fosphenytoin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00106	CcSEcCtD
Fosphenytoin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00105	CcSEcCtD
Fosphenytoin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00105	CcSEcCtD
Fosphenytoin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00105	CcSEcCtD
Fosphenytoin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000185	0.00105	CcSEcCtD
Fosphenytoin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00105	CcSEcCtD
Fosphenytoin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00105	CcSEcCtD
Fosphenytoin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.00104	CcSEcCtD
Fosphenytoin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00104	CcSEcCtD
Fosphenytoin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00104	CcSEcCtD
Fosphenytoin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00104	CcSEcCtD
Fosphenytoin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00102	CcSEcCtD
Fosphenytoin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00102	CcSEcCtD
Fosphenytoin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00101	CcSEcCtD
Fosphenytoin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.001	CcSEcCtD
Fosphenytoin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.000989	CcSEcCtD
Fosphenytoin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000979	CcSEcCtD
Fosphenytoin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000964	CcSEcCtD
Fosphenytoin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000964	CcSEcCtD
Fosphenytoin—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000169	0.00384	CbGpPWpGaD
Fosphenytoin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00095	CcSEcCtD
Fosphenytoin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00095	CcSEcCtD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00379	CbGpPWpGaD
Fosphenytoin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000949	CcSEcCtD
Fosphenytoin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000944	CcSEcCtD
Fosphenytoin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000931	CcSEcCtD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.0037	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000919	CcSEcCtD
Fosphenytoin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000919	CcSEcCtD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000161	0.00366	CbGpPWpGaD
Fosphenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00365	CbGpPWpGaD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00364	CbGpPWpGaD
Fosphenytoin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00091	CcSEcCtD
Fosphenytoin—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00362	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000159	0.0009	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000158	0.00359	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000158	0.00359	CbGpPWpGaD
Fosphenytoin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000897	CcSEcCtD
Fosphenytoin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000888	CcSEcCtD
Fosphenytoin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000888	CcSEcCtD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00351	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00349	CbGpPWpGaD
Fosphenytoin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00087	CcSEcCtD
Fosphenytoin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000868	CcSEcCtD
Fosphenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00346	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000151	0.00342	CbGpPWpGaD
Fosphenytoin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000151	0.000854	CcSEcCtD
Fosphenytoin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.000854	CcSEcCtD
Fosphenytoin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000847	CcSEcCtD
Fosphenytoin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000847	CcSEcCtD
Fosphenytoin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000846	CcSEcCtD
Fosphenytoin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000846	CcSEcCtD
Fosphenytoin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000842	CcSEcCtD
Fosphenytoin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000842	CcSEcCtD
Fosphenytoin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000839	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000839	CcSEcCtD
Fosphenytoin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000148	0.000837	CcSEcCtD
Fosphenytoin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00083	CcSEcCtD
Fosphenytoin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000829	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000827	CcSEcCtD
Fosphenytoin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000824	CcSEcCtD
Fosphenytoin—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00323	CbGpPWpGaD
Fosphenytoin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000806	CcSEcCtD
Fosphenytoin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000804	CcSEcCtD
Fosphenytoin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000801	CcSEcCtD
Fosphenytoin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.0008	CcSEcCtD
Fosphenytoin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000799	CcSEcCtD
Fosphenytoin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000799	CcSEcCtD
Fosphenytoin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000798	CcSEcCtD
Fosphenytoin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000798	CcSEcCtD
Fosphenytoin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000795	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000139	0.00314	CbGpPWpGaD
Fosphenytoin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000783	CcSEcCtD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00313	CbGpPWpGaD
Fosphenytoin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000782	CcSEcCtD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00312	CbGpPWpGaD
Fosphenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00309	CbGpPWpGaD
Fosphenytoin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000772	CcSEcCtD
Fosphenytoin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00077	CcSEcCtD
Fosphenytoin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000758	CcSEcCtD
Fosphenytoin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000753	CcSEcCtD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.003	CbGpPWpGaD
Fosphenytoin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00075	CcSEcCtD
Fosphenytoin—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00295	CbGpPWpGaD
Fosphenytoin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000727	CcSEcCtD
Fosphenytoin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00286	CbGpPWpGaD
Fosphenytoin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000716	CcSEcCtD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00284	CbGpPWpGaD
Fosphenytoin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00071	CcSEcCtD
Fosphenytoin—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000125	0.00282	CbGpPWpGaD
Fosphenytoin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000703	CcSEcCtD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00279	CbGpPWpGaD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00276	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000116	0.00264	CbGpPWpGaD
Fosphenytoin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000658	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000653	CcSEcCtD
Fosphenytoin—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000115	0.00261	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000113	0.00256	CbGpPWpGaD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00255	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00254	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000111	0.00252	CbGpPWpGaD
Fosphenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00251	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000107	0.00241	CbGpPWpGaD
Fosphenytoin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000601	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000599	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000599	CcSEcCtD
Fosphenytoin—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000105	0.00239	CbGpPWpGaD
Fosphenytoin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000595	CcSEcCtD
Fosphenytoin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000104	0.00236	CbGpPWpGaD
Fosphenytoin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000584	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000582	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000581	CcSEcCtD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00231	CbGpPWpGaD
Fosphenytoin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000578	CcSEcCtD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00228	CbGpPWpGaD
Fosphenytoin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000569	CcSEcCtD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00226	CbGpPWpGaD
Fosphenytoin—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000561	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000559	CcSEcCtD
Fosphenytoin—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.86e-05	0.00223	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.78e-05	0.00222	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.74e-05	0.00221	CbGpPWpGaD
Fosphenytoin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000551	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000551	CcSEcCtD
Fosphenytoin—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.68e-05	0.00219	CbGpPWpGaD
Fosphenytoin—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000545	CcSEcCtD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.54e-05	0.00216	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	9.43e-05	0.00213	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.39e-05	0.00213	CbGpPWpGaD
Fosphenytoin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000529	CcSEcCtD
Fosphenytoin—Infection—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000525	CcSEcCtD
Fosphenytoin—Shock—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.00052	CcSEcCtD
Fosphenytoin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00208	CbGpPWpGaD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.12e-05	0.00207	CbGpPWpGaD
Fosphenytoin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000516	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000511	CcSEcCtD
Fosphenytoin—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	8.97e-05	0.00203	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	8.9e-05	0.00202	CbGpPWpGaD
Fosphenytoin—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000504	CcSEcCtD
Fosphenytoin—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.8e-05	0.00199	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.7e-05	0.00197	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.67e-05	0.00196	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.67e-05	0.00196	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.66e-05	0.00196	CbGpPWpGaD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000482	CcSEcCtD
Fosphenytoin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000481	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.000478	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.38e-05	0.000475	CcSEcCtD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.28e-05	0.00187	CbGpPWpGaD
Fosphenytoin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000465	CcSEcCtD
Fosphenytoin—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.19e-05	0.00186	CbGpPWpGaD
Fosphenytoin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.00046	CcSEcCtD
Fosphenytoin—Rash—Prednisolone—chronic obstructive pulmonary disease	8.09e-05	0.000459	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.09e-05	0.000458	CcSEcCtD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.00183	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.07e-05	0.00183	CbGpPWpGaD
Fosphenytoin—Headache—Prednisolone—chronic obstructive pulmonary disease	8.04e-05	0.000456	CcSEcCtD
Fosphenytoin—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.02e-05	0.00182	CbGpPWpGaD
Fosphenytoin—Constipation—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000452	CcSEcCtD
Fosphenytoin—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.96e-05	0.0018	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.95e-05	0.0018	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.93e-05	0.0018	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.78e-05	0.00176	CbGpPWpGaD
Fosphenytoin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000436	CcSEcCtD
Fosphenytoin—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.62e-05	0.000432	CcSEcCtD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.51e-05	0.0017	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.43e-05	0.00168	CbGpPWpGaD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.42e-05	0.00168	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.42e-05	0.00168	CbGpPWpGaD
Fosphenytoin—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.00042	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000418	CcSEcCtD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.32e-05	0.00166	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.31e-05	0.00166	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.31e-05	0.00166	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.00163	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.08e-05	0.0016	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.04e-05	0.0016	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.03e-05	0.00159	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.00157	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.93e-05	0.00157	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.89e-05	0.00156	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.89e-05	0.00156	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.83e-05	0.00155	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.81e-05	0.00154	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.74e-05	0.00153	CbGpPWpGaD
Fosphenytoin—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.69e-05	0.000379	CcSEcCtD
Fosphenytoin—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.67e-05	0.00151	CbGpPWpGaD
Fosphenytoin—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000374	CcSEcCtD
Fosphenytoin—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.57e-05	0.00149	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000362	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.28e-05	0.00142	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.28e-05	0.00142	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.0014	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.18e-05	0.0014	CbGpPWpGaD
Fosphenytoin—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.00035	CcSEcCtD
Fosphenytoin—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.1e-05	0.00138	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.01e-05	0.00136	CbGpPWpGaD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.01e-05	0.00136	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.00135	CbGpPWpGaD
Fosphenytoin—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000336	CcSEcCtD
Fosphenytoin—Rash—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000333	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000333	CcSEcCtD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.00133	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.85e-05	0.00133	CbGpPWpGaD
Fosphenytoin—Headache—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000331	CcSEcCtD
Fosphenytoin—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	5.66e-05	0.00128	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.64e-05	0.00128	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.6e-05	0.00127	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.6e-05	0.00127	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.56e-05	0.00126	CbGpPWpGaD
Fosphenytoin—Nausea—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000314	CcSEcCtD
Fosphenytoin—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.00125	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.5e-05	0.00124	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.48e-05	0.00124	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.31e-05	0.0012	CbGpPWpGaD
Fosphenytoin—Modafinil—CYP1A2—chronic obstructive pulmonary disease	5.31e-05	0.661	CrCbGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.29e-05	0.0012	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.00119	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.23e-05	0.00118	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.11e-05	0.00116	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.11e-05	0.00116	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.11e-05	0.00116	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.07e-05	0.00115	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.04e-05	0.00114	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.93e-05	0.00112	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.87e-05	0.0011	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.84e-05	0.0011	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.79e-05	0.00108	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.78e-05	0.00108	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.76e-05	0.00108	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.69e-05	0.00106	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.51e-05	0.00102	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.47e-05	0.00101	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.47e-05	0.00101	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.43e-05	0.001	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.4e-05	0.000996	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.34e-05	0.000982	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.27e-05	0.000968	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.13e-05	0.000934	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.06e-05	0.00092	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.99e-05	0.000903	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.9e-05	0.000883	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.87e-05	0.000877	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.75e-05	0.000848	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.67e-05	0.00083	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.64e-05	0.000825	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.62e-05	0.000819	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.52e-05	0.000797	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.47e-05	0.000787	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.41e-05	0.000773	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.39e-05	0.000769	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.39e-05	0.000767	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.37e-05	0.000763	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.32e-05	0.000753	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.3e-05	0.000747	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.28e-05	0.000742	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000723	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.17e-05	0.000718	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.16e-05	0.000716	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.15e-05	0.000714	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000714	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.15e-05	0.000712	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.13e-05	0.000709	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.000708	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.09e-05	0.000699	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.07e-05	0.000695	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.06e-05	0.000694	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.05e-05	0.00069	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.9e-05	0.000657	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.87e-05	0.00065	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.85e-05	0.000646	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.84e-05	0.000644	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.000641	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.81e-05	0.000636	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.78e-05	0.000629	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.75e-05	0.000624	CbGpPWpGaD
Fosphenytoin—Phenytoin—ALB—chronic obstructive pulmonary disease	2.72e-05	0.339	CrCbGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.71e-05	0.000613	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.58e-05	0.000585	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.57e-05	0.000582	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.00058	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.56e-05	0.00058	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.51e-05	0.000569	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.45e-05	0.000554	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.33e-05	0.000529	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.000518	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.000515	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.27e-05	0.000514	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.24e-05	0.000507	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.2e-05	0.000498	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.19e-05	0.000495	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.08e-05	0.000472	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000462	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.02e-05	0.000457	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000451	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000446	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000421	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000407	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.7e-05	0.000386	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.7e-05	0.000385	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000382	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.00038	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000377	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000375	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.66e-05	0.000375	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000375	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.62e-05	0.000368	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.55e-05	0.000352	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000349	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000344	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.51e-05	0.000342	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.000341	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000337	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000317	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.000315	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000314	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.000313	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000311	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000308	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000307	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000307	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.000287	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000286	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.25e-05	0.000283	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.00028	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000272	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.17e-05	0.000265	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000265	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.000263	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000261	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000259	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000258	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000243	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.07e-05	0.000243	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000242	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000236	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000233	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.00023	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000229	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.58e-06	0.000217	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.51e-06	0.000215	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.38e-06	0.000212	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.08e-06	0.000206	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.05e-06	0.000205	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.94e-06	0.000203	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.83e-06	0.0002	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.74e-06	0.000198	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.28e-06	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	8.17e-06	0.000185	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.16e-06	0.000185	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.82e-06	0.000177	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.52e-06	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.92e-06	0.000157	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.62e-06	0.00015	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.58e-06	0.000149	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.27e-06	0.000142	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.18e-06	0.00014	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.18e-06	0.00014	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.91e-06	0.000134	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.76e-06	0.000131	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.63e-06	0.000128	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-06	0.000124	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.39e-06	0.000122	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-06	8.41e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-06	8.04e-05	CbGpPWpGaD
